AP454A - Therapeutic compounds with hydroxamic acid derivatives. - Google Patents

Therapeutic compounds with hydroxamic acid derivatives. Download PDF

Info

Publication number
AP454A
AP454A APAP/P/1994/000637A AP9400637A AP454A AP 454 A AP454 A AP 454A AP 9400637 A AP9400637 A AP 9400637A AP 454 A AP454 A AP 454A
Authority
AP
ARIPO
Prior art keywords
compound
formula
physiologically functional
solvate
fluoro
Prior art date
Application number
APAP/P/1994/000637A
Other languages
English (en)
Other versions
AP9400637A0 (en
Inventor
Simon Teanby Hodgson
Peter John Wates
Original Assignee
The Wellcome Foundation Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB939308652A external-priority patent/GB9308652D0/en
Priority claimed from GB939318432A external-priority patent/GB9318432D0/en
Application filed by The Wellcome Foundation Ltd filed Critical The Wellcome Foundation Ltd
Publication of AP9400637A0 publication Critical patent/AP9400637A0/xx
Application granted granted Critical
Publication of AP454A publication Critical patent/AP454A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C275/00Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C275/64Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C17/00Preparation of halogenated hydrocarbons
    • C07C17/26Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton
    • C07C17/263Preparation of halogenated hydrocarbons by reactions involving an increase in the number of carbon atoms in the skeleton by condensation reactions
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/53Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C259/00Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
    • C07C259/04Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
    • C07C259/06Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C33/00Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C33/28Alcohols containing only six-membered aromatic rings as cyclic part with unsaturation outside the aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/61Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
    • C07C45/67Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
    • C07C45/68Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • C07C45/72Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms by reaction of compounds containing >C = O groups with the same or other compounds containing >C = O groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/20Unsaturated compounds containing keto groups bound to acyclic carbon atoms
    • C07C49/227Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen
    • C07C49/233Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings
    • C07C49/235Unsaturated compounds containing keto groups bound to acyclic carbon atoms containing halogen containing six-membered aromatic rings having unsaturation outside the aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
APAP/P/1994/000637A 1993-04-27 1994-04-26 Therapeutic compounds with hydroxamic acid derivatives. AP454A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939308652A GB9308652D0 (en) 1993-04-27 1993-04-27 Anti-inflammatory compounds
GB939318432A GB9318432D0 (en) 1993-09-06 1993-09-06 Anti-inflammatory compounds

Publications (2)

Publication Number Publication Date
AP9400637A0 AP9400637A0 (en) 1994-04-30
AP454A true AP454A (en) 1996-01-19

Family

ID=26302815

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1994/000637A AP454A (en) 1993-04-27 1994-04-26 Therapeutic compounds with hydroxamic acid derivatives.

Country Status (9)

Country Link
EP (1) EP0696272A1 (is)
JP (1) JPH08509718A (is)
AP (1) AP454A (is)
AU (1) AU6575094A (is)
CA (1) CA2161544A1 (is)
HU (1) HUT71556A (is)
IL (1) IL109430A0 (is)
TW (1) TW269679B (is)
WO (1) WO1994025431A1 (is)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996023772A1 (fr) * 1995-02-02 1996-08-08 Nikken Chemicals Co., Ltd. Derives de n-hydroxyuree
DE69635048T2 (de) * 1995-06-12 2006-02-16 G.D. Searle & Co. Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor
CN1315858A (zh) * 1998-07-17 2001-10-03 富士药品工业株式会社 新型过敏性疾病的治疗剂
US6858598B1 (en) 1998-12-23 2005-02-22 G. D. Searle & Co. Method of using a matrix metalloproteinase inhibitor and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
US6833373B1 (en) 1998-12-23 2004-12-21 G.D. Searle & Co. Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
AR038957A1 (es) 2001-08-15 2005-02-02 Pharmacia Corp Terapia de combinacion para el tratamiento del cancer
MXPA04007870A (es) 2002-02-15 2005-06-20 Endorech Inc Derivados de bifenilo y su uso como agentes antiandrogenicos.
CN112358416B (zh) * 2020-11-03 2021-10-15 北京科技大学 一种反式-3-氯-2-丙烯基羟胺的制备方法

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196184A2 (en) * 1985-03-16 1986-10-01 The Wellcome Foundation Limited Aryl derivatives
EP0351214A1 (en) * 1988-07-14 1990-01-17 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0196184A2 (en) * 1985-03-16 1986-10-01 The Wellcome Foundation Limited Aryl derivatives
EP0351214A1 (en) * 1988-07-14 1990-01-17 The Wellcome Foundation Limited Anti-inflammatory aryl derivatives

Also Published As

Publication number Publication date
HUT71556A (en) 1995-12-28
TW269679B (is) 1996-02-01
WO1994025431A1 (en) 1994-11-10
HU9501810D0 (en) 1995-08-28
EP0696272A1 (en) 1996-02-14
AP9400637A0 (en) 1994-04-30
AU6575094A (en) 1994-11-21
JPH08509718A (ja) 1996-10-15
CA2161544A1 (en) 1994-11-10
IL109430A0 (en) 1994-07-31

Similar Documents

Publication Publication Date Title
US5155110A (en) Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
JP2818820B2 (ja) 抗炎症剤としての3−アリール−2−イソオキサゾリン類
JPS61229845A (ja) ヒドロキサメート類
JPH07103056B2 (ja) 神経細胞変性修復又は保護剤
FR2596049A1 (fr) Derives de dichloroaniline
FR2849032A1 (fr) Derive de 5-(4-bromophenyl)-1-(2,4-dichlorophenyl)-4-ethyl-n -(piperidin-1-yl)-1h-pyrazole-3-carboxamide, sa preparation, son application en therapeuthique
JPH10182583A (ja) 新規ヒドロキサム酸誘導体
PL154186B1 (en) Method for manufacturing arylic derivatives of the hydroxamic acid
HU197559B (en) Process for producing new aromatic carboxamide derivatives and pharmaceuticals comprising same as active ingredient
AP454A (en) Therapeutic compounds with hydroxamic acid derivatives.
KR20170090497A (ko) 디히드로피리미딘-2-온 화합물 및 그의 의약 용도
AU672810B2 (en) Hydroxamic acid derivatives and their use as anti-inflammatory compounds
US7446229B2 (en) Bicyclic cannabinoids
JPH05221980A (ja) アセチレン化合物
JPH06511238A (ja) インドール誘導体
EP0558563B1 (en) Anti-inflammatory compounds
EP0055418B1 (en) Pyrazoline derivatives, processes for their preparation and pharmaceutical formulations containing them
JP2009520710A (ja) オキサフェナントレン誘導体
US4564684A (en) 3-Amino-1-phenyl-2-pyrazolines
WO1994025430A1 (en) Cyclooxygenase and 5-lipoxygenase inhibiting hydroxamic acid derivatives
JP2002524553A (ja) 新規化合物
US5045562A (en) 1,3,5-trithiane derivatives and pharmaceutical compositions thereof
AU4698293A (en) Isoserine derivatives and their use as leukotriene antagonists
US4906658A (en) Fluoro-sulfones
EP0119449A1 (en) Aminopyrazoline derivatives